Reuters logo
BRIEF-Enanta Pharmaceuticals announces new data presentations on EDP-305
September 27, 2017 / 8:57 PM / 3 months ago

BRIEF-Enanta Pharmaceuticals announces new data presentations on EDP-305

Sept 27 (Reuters) - Enanta Pharmaceuticals Inc

* Enanta Pharmaceuticals announces new data presentations on EDP-305, an FXR agonist for NASH and PBC, at The Liver Meeting 2017

* Co has submitted an abstract to AASLD for consideration of late breaking data from its phase 1 clinical study of EDP-305​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below